Infectious Disease Advisor news story
Recombinant zoster vaccination may reduce incident heart failure risk in adults with HIV, providing a protective effect against risks heightened by herpes zoster, according to research presented at IDWeek 2026, held from October 21 to 24, in Washington, DC.
HIV infection is associated with increased cardiovascular risk due to chronic immune activation. To further explore the role of this immune activation in cardiovascular outcomes, researchers conducted complementary, retrospective, 1:1 propensity-score matched cohort analyses using data from TriNetX of adults with HIV receiving antiretroviral therapy.
Read the full news story here.
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
View all Infectious Disease Advisor reports from IDWeek 2026
Source : Infectious Disease Advisor
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.